Table 5.
Delay or continuation of BMT and other procedures in FA-RP positive patients
| Procedure | No. that continued with procedure (%) | No. positive tests where procedure continued (%) | Target detected (n) | No. with delayed procedure due to positive test | Target detected (n) | |
|---|---|---|---|---|---|---|
| BMT procedures (n = 91) | Allogenic BMT | 45 (49.5) | 9/45 (20) |
hRV/hEV (5) PIVs (2) hCoV OC43 (1) hCoV OC43_hRV/hEV (1) |
1 | RSV |
| Autologous BMT | 20 (22) | 10/20 (50) |
hRV/hEV (8) hCoV HKU1 (1) RSV (1) |
- | - | |
| CAR T cell | 23 (25.3) | 11/23 (47.8) |
hRV/hEV (8) PIVs (1) RSV (1) hCoV OC43_hRV/EV (1) |
2 |
hRV/hEV RSV |
|
| Other procedures (n = 16) | Chemotherapy | 4 (25) | 1/4 (25) | hRV/hEV (1) | 3 |
RV/EV (2) FluA (1) |
| Line or catheter placement under anesthesia | 8 (50) | 7/8 (87.5) |
hRV/hEV (6) PIVs (1) |
1 | RSV |
Abbreviations: FA-RP, Film Array Respiratory Panel; BMT, bone marrow transplant; No., number; hRV/hEV, human rhinovirus/enterovirus; PIVs, parainfluenza viruses; hCoV, human coronavirus; RSV, respiratory syncytial virus; BMA, bone marrow aspiration